Status:
UNKNOWN
Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis
Lead Sponsor:
Christine M. Kleinert Institute for Hand and Microsurgery
Collaborating Sponsors:
Kleinert, Kutz and Associates
Conditions:
Pain
Satisfaction, Patient
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The evolving reports form recent studies are creating a promise on the potential use of dextrose injections for treating arthritis and replacing current method of treating early osteoarthritis by cort...
Detailed Description
Carpometacarpal osteoarthritis (OA) is a degenerative condition of the hand that causes pain, stiffness and weakness. It is the second most common site of degenerative disease in the hand after arthri...
Eligibility Criteria
Inclusion
- Those patients with diagnosis of carpometacarpal (CMC) osteoarthritis
- Those patients who fit the age limits
Exclusion
- Those patients outside of the age limits
- Those patients with systemic rheumatic disease, comorbid hand conditions (such as carpal tunnel syndrome or De Quervain's tenosynovitis), gout, pseudogout
- Those patients with a predisposition to bleeding issues
- Those patients with previous surgery to the affected thumb
- Those patients with previous injection to the involved thumb base within the past 12 months
- Those patients with severe X-ray osteoarthritis of grade IV (Eaton and Littler classification) and no evidence of CMC joint space narrowing on plain radiographs
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04791202
Start Date
April 1 2021
End Date
July 1 2022
Last Update
March 16 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.